Google Alert - pharmaceutical news

News 8 new results for pharmaceutical news

Physicians and pharmaceutical industry DAWN.com ZUBEIDA Mustafa's op-ed piece 'Physician heal thyself' (May 2) has highlighted the unethical practices of the pharmaceutical industry and Pakistani physicians being willing partners in this. It is because of the huge profits at stake that the industry ... See all stories on this topic »

Supernus Pharmaceuticals Closes 10M IPO Citybizlist (press release) ROCKVILLE, Md., -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), today announced the closing of its initial public offering of 10000000 of its common stock at a price of $5.00 per share. The Company's shares are listed on The NASDAQ Global Market under ... See all stories on this topic »

<B>Letters:</B> Patently right Business Standard (blog) Apropos the article "The myth of coalition compulsions (May 3), it is misleading of Ravi Shanker Kapoor to say compulsory licensing for pharmaceutical products is restrictive. It is, in fact, just the opposite. Here is what the Brides Weekly Trade News ... See all stories on this topic »

Avomeen Analytical Services Opens Newly Renovated Pharmaceutical Research and ... Healthcare Global (press release) Source: Avomeen Analytical Services Ann Arbor, MI, May 05, 2012 --(PR.com)-- Avomeen Analytical Services, an Ann Arbor, Michigan based independent testing laboratory has announced opening of newly renovated pharmaceutical research and development ... See all stories on this topic »

Pharmacy grads blessed with brisk job offers The Daily Yomiuri While most university graduates are grappling with a tight labor market, students who graduated from pharmaceutical colleges or departments in March have been spoiled for choice. Demand for these students has soared because they are the first batch to ... See all stories on this topic » The Daily Yomiuri

Latuda® (lurasidone HCl) Label Updated With Expanded Dosing Range Providing ... EON: Enhanced Online News (press release) (EON: Enhanced Online News)--Sunovion Pharmaceuticals Inc. today announced that the US Food and Drug Administration (FDA) has approved an expanded dose range for LATUDA in the treatment of adult patients with schizophrenia. The FDA decision followed a ... See all stories on this topic »

Is the grass greener elsewhere? Express Healthcare After hearing representatives of the pharmaceutical as well as hospital industry during our panel discussion on Universal Access to Health, I was struck by what seemed like a universal truth: industry complains, government prevails. See all stories on this topic » Express Healthcare

Pharma rushes to avoid falling off 'patent cliff' Financial Times Along with many of his peers in the pharmaceutical industry, he faces a "patent cliff" of expiries that has pushed companies to adopt widely divergent responses and helps explain a recent flurry of licensing deals and acquisitions. See all stories on this topic »

---

Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.